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Distal pancreatectomy is the standard curative treatment for symptomatic benign, premalignant, and malignant disease of the
pancreatic body and tail.Themost obvious benefits of a laparoscopic approach to distal pancreatectomy include earlier recovery and
shorter hospital stay. Spleen-preserving distal pancreatectomy should be attempted in case of benign disease. Spleen preservation
can be achieved preferably by preserving the splenic vessels (Kimura technique), but also by resecting the splenic vessels and
maintaining vascularity through the short gastric vessels and left gastroepiploic artery (Warshaw technique). Several studies have
suggested a higher rate of spleen preservation with laparoscopy.The radical antegrade modular pancreatosplenectomy has become
mainstay for treating pancreatic cancer and can be performed laparoscopically as well. Evidence on the feasibility and safety of
laparoscopic distal pancreatectomy for cancer is scarce. Despite the obvious advantages of laparoscopic surgery, postoperative
morbidity remains relatively high, mainly because of the high incidence of pancreatic fistula. For decades, surgeons have tried
to prevent these fistulas but to date no strategy has been confirmed to be effective in 2 consecutive randomized studies. Pragmatic
multicenter studies focusing on technical aspects of laparoscopic distal pancreatectomy are lacking and should be encouraged.
1. Introduction
Distal pancreatectomy is the standard treatment for symp-
tomatic benign, premalignant, and malignant lesions in the
pancreatic body and tail. Distal pancreatectomy includes
resection of pancreatic tissue to the left of the portome-
senteric vein and can be extended with lymphadenectomy
and splenectomy in case of malignant disease. Through the
years, this procedure has been tailored to specific indications
with the objective of improving postoperative outcomes and
minimizing patient trauma. A laparoscopic approach to distal
pancreatectomy has been suggested to be associated with
reduced postoperative morbidity and hospital stay compared
with open surgery [1, 2].However, this approach is considered
to be technicallymore demanding than conventional surgery.
In case of symptomatic benign or premalignant disease,
attempts should be made to preserve the spleen, with either
splenic vessel preservation (described by Kimura et al. [3]) or
resection of the splenic vessels (described by Warshaw [4]),
because a splenectomy is incapacitating for patients as it
necessitates vaccinations and supply of antibiotics in order
to prevent potentially lethal postsplenectomy sepsis. Also, in
order to prevent overwhelming postsplenectomy sepsis, the
use of antibiotic prophylaxis after splenectomy is advised by
several guidelines worldwide [5].
Unfortunately, the rate of pancreatic fistula after distal
pancreatectomy (POPF) remains high. Surgeons have tried to
prevent these fistulas for decades, but to date no strategy has
been confirmed to be effective in 2 consecutive randomized
controlled studies.
This paper focusses on evidence-based technical aspects
of laparoscopic distal pancreatectomy.
2. Methods
A systematic literature search was performed in PubMed
for studies published up to November 1, 2014. Search terms
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included “technical aspects,” “laparoscopy,” “pancreatec-
tomy,” “splenectomy,” “spleen preservation,” “radical ante-
grademodular pancreatosplenectomy,” “fistula,” and relevant
synonyms. Titles and abstracts of all articles were screened for
eligibility. Subsequently, full-text English articles on the tech-
nique of laparoscopic distal pancreatectomy and prevention
of POPF were included in this study. Articles with the highest
methodological quality were selected for inclusion, for every
topic separately.
3. Results
3.1. Laparoscopic Distal Pancreatectomy. Benign neoplasms
of the distal pancreas only have to be treated in case of
incapacitating symptoms. Premalignant neoplasms have to
be resected to prevent the progression to cancer. For pan-
creatic cancer, surgery is the only potential curative therapy.
Until recently, distal pancreatectomy was a relatively rare
procedure, mainly due to the low incidence of pancreatic
tumors and the high proportion of unresectable disease at
first presentation. In last years, the total amount of distal
pancreatectomies performed each year has increased and this
is suspected to be mainly because of the increased use and
improved quality of diagnostic imaging, causing subsequent
detection of pancreatic cysts [7]. A laparoscopic approach to
distal pancreatectomy is gaining popularity and is by some
considered the standard approach to distal pancreatectomy
for benign and premalignant disease [8]. However, this
procedure can be technically demanding and should be
performed only by surgeons with sufficient experience in
both open pancreatic surgery and advanced laparoscopic
gastrointestinal surgery [9].
Especially in the beginning of the 21st century, many
cohort series on laparoscopic distal pancreatectomy appeared
[10]. As a logical consequence, in the past 3 years, several
systematic reviews and meta-analyses on laparoscopic versus
open distal pancreatectomy have been published [1, 2, 11–17].
From these meta-analyses it can be concluded that the
most obvious benefits of laparoscopic distal pancreatectomy
compared with open distal pancreatectomy are a postoper-
ative earlier recovery, a reduced length of hospital stay, and
potentially a higher spleen preservation rate [1, 2, 11–16, 18].
The benefit of the laparoscopic approach regarding reduced
hospital stay remains also in case-matched studies [15].
Unfortunately, randomized controlled studies have not been
performed.
Only a small minority of studies on laparoscopic versus
open distal pancreatectomy focused on cancer. In previous
studies on open surgery for cancer, the radical antegrade
modular pancreatosplenectomy (RAMPS) seemed superior
to conventional distal pancreatectomy concerning radical
resection margins and lymphadenectomy [19], but large
cohorts of laparoscopic RAMPS procedures are lacking.
Surgeons should not be hesitant to convert a laparoscopic
distal pancreatectomy or RAMPS procedure to an open
procedure if patient safety including oncological efficacy
is compromised. Within the current literature, conversion
rates range from 0% to 33% and this may be related to






© Van der Zon-Visueel
Figure 1: Trocar placement for laparoscopic distal pancreatectomy.
Transparent 5mm trocar is the additional trocar recommended
during laparoscopic distal pancreatectomy for cancer as it will
facilitate lymphadenectomy at the hepatic artery and celiac trunk.
complication [20–24]. Main reasons in the literature for
conversion from laparoscopic to open distal pancreatectomy
are severe bleeding, extensive tumor growth, and lack of
progress [21, 23, 25].
3.1.1. Trocars and Mobilization of the Pancreas. The tech-
nique of laparoscopic distal pancreatectomy can vary widely
between different surgeons and centers. Several studies
reported low intraoperative blood losses, short operative
times, and low conversion rates [26–30]. The technique used
in these series was comparable in several aspects. Four to
five trocars are placed in a semicircular fashion centered
around an umbilical camera, as shown in Figure 1. The
gastrocolic ligament is opened with an energy device, while
preserving the gastroepiploic vessels. The stomach is lifted
with a suture to permit access to the lesser sac and good
exposure of the pancreas. Two large bites of a nontied
suture through the posterior fundus are used, which are
then led out next to the epigastric port (shown in Figure 1)
[26, 27]. Alternatively, the stomach can be retracted with a
laparoscopic retractor device. Intraoperative ultrasound can
be performed at this stage, to define the precise location of
the lesion, its relation to the splenic vessels, and the level of
resection needed. Then the pancreas can be mobilized, first
by mobilizing the inferior pancreatic border, which creates
access to the posterior pancreatic surface. Further dissection
of the superior pancreatic border permits placement of a
nylon tape around the pancreas. This nylon tape can be
used to delineate the surgical planes and to enable further
mobilization. During laparoscopic distal pancreatectomy,
the best option is to first transect the pancreas and then
separate the splenic vessels from the pancreatic specimen
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in a medial to lateral approach using electrocautery or/and
an ultrasonic/sealing device. Small vessels from the splenic
artery or vein to the pancreas can be transected.This has to be
performedwith caution, as bleeding posterior to the pancreas
may be difficult to control and necessitates occlusion of the
splenic blood flow. Slinging the pancreas at both sides of the
tumor with nylon tape and splenic vessels with vessel loops
delineates the surgical plain and ensures a better surveillance
of peripancreatic tissue. The pancreas and splenic vessels can
be easily secluded from surrounding structures using this
technique, which simplifies pancreatic transection without
damaging main vessels [28–30]. Slinging the splenic vessels
with vessel loops is facilitated by using a laparoscopic 90-
degree serrated grasper. If the lesion is located distally in the
tail, a lateral to medial dissection can be attempted.
3.1.2. Spleen Preservation. Distal pancreatectomy with sub-
sequent splenectomy is indicated in case of malignant dis-
ease of the distal pancreas to ensure extensive resection
of lymph nodes located along the splenic artery and the
splenic hilum [6, 31]. Splenectomy is also often performed
because of technical reasons, such as vascular tumor involve-
ment, but potentially because spleen preservation can be
technically challenging. However, in case of nonmalignant
disease, preservation of the spleen is advised, as spleen
preservation was seen to be associated with a reduction
of perioperative infections and length of hospital stay [5,
32–34]. The introduction of the laparoscopic approach in
distal pancreatectomy has been associated with higher rates
of spleen-preserving distal pancreatectomy (odds ratio of 3
for laparoscopy compared with open surgery), as shown in
several systematic reviews [12–14]. Although the exact expla-
nation is lacking, it has been suggested that the enhanced
view during laparoscopic surgery with better visualization of
splenic vessels has contributed to this finding.
In 1996, a technique of spleen-preserving distal pan-
createctomy was described by Kimura et al. [3], including
preservation of the splenic artery and vein. The authors
concluded that this procedure is easy and safe. Contradictory
to this statement, this spleen-preserving technique is known
to be technically demanding, as the splenic vessels have to
be dissected circumferentially and have to be separated from
the pancreas carefully. In case of proven benign disease,
this procedure is indicated. In case of premalignant disease,
this procedure is indicated when the lesion is not attached
to the spleen or splenic vessels. Otherwise, respectively, a
subsequent splenectomy or spleen-preserving distal pancre-
atectomy with resection of the splenic vessels has to be
performed.
In 1988, a spleen-preserving distal pancreatectomy with
transection of the splenic vessels was introduced byWarshaw
[4]. During this procedure, now often referred to as the
Warshaw technique, the splenic artery and vein are transected
at the side of the portomesenteric vein and at the splenic
hilum. Vascular control can be achieved with Hem-o-lok
clips (Teleflex Medical, Weck Drive, Research Triangle Park,
NC, USA) or staplers [27, 35]. It is important to emphasize
that two Hem-o-lok clips are needed to secure the vessels.
An adequate vascular cuff should be left to preclude the clips
from slipping off.
It is unclear whether the Kimura or Warshaw technique
is superior [36–38]. However, a recent systematic review
reported more spleen-related complications after the War-
shaw technique compared with the Kimura technique, such
as need for postoperative splenectomy (2% versus 0%, 𝑃 =
0.001), (partial) splenic infarction (22% versus 2%, 𝑃 <
0.001), and chronic abdominal pain (38% versus 0%, 𝑃 =
0.048) [39]. Therefore, first a Kimura technique should be
attempted, with initially preserving the short gastric arteries.
When this technique is not feasible, a Warshaw technique
can be performed (Figure 2). In this scenario, the splenic
vessels are transected. Attention should be given to preserve
the left gastroepiploic artery, as this is suspected to play an
important role in the prevention of postoperative splenic
ischemia (Figure 3). A vascular endostapler is also a good
option for vessel transection, but this may be too bulky.
Again, slinging the splenic vessels with vessel loops ensures
clipping and transecting these vessels easily.When aWarshaw
technique is applied to preserve the spleen, the use of a
bulldog arterial clamp is optional and temporarily decreases
the splenic blood flow. During this procedure, alternatively
the splenic artery could subsequently be dissected medially
to the level of the potential pancreatic resection line before
transecting the pancreas [28].
During a spleen-preserving procedure the surgeon
should always examine the splenic perfusion at the end of
the procedure. When signs of splenic ischemia are present,
such as extensive ischemic zones, a splenectomy has to be
performed. This may occur in 10% of patients [36].
3.1.3. Technique for Pancreatic Cancer. Survival after distal
pancreatectomy for pancreatic cancer is poor. To improve
these outcomes, the RAMPS was developed by Strasberg et
al., which is based on a medial to lateral resection, a posterior
dissection plane, resection of Gerota’s fascia (and optional
(i.e., “modular”) the left adrenal gland), and adequate lymph
node dissection [31]. Before starting RAMPS, a staging
laparoscopy is indicated to rule out peritoneal or liver metas-
tases. When the adrenal gland is not involved, an anterior
RAMPS can be performed, always including resection of
Gerota’s fascia. Whenever the posterior margin of the tumor
seems to involve the adrenal gland, a posterior RAMPS
should be performed, including resection of involved organs
(e.g., adrenal gland or kidney). During both the anterior and
posterior RAMPS, additional lymph node dissection along
the celiac trunk is performed, based on the pancreatic lymph
node system as described by O’Morchoe [40]. However,
a recent consensus statement of the International Study
Group on Pancreatic Surgery specified that lymph node
dissection of stations 8 and 9 along the common hepatic
artery and the celiac trunk has to be performed only in case
of malignant tumors of the body of the pancreas [6]. They
stated that lymphadenectomy of station 10 (in the splenic
hilum), station 11 (along the splenic artery), and station 18
(along the inferior border of the pancreatic body and tail)
should be mandatory during all distal pancreatectomies for
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Tumor not attached to spleen or splenic vessel(s) Tumor attached to spleen
Diagnosis
Nonmalignant tumor Malignant tumor (potential)
Not feasibleNot feasible




Open surgery Tumor confined to the pancreas Tumor involving adrenal gland
Kimura∗ Warshaw #
Posterior RAMPS∧Anterior RAMPS∧
Distal pancreatectomy + splenectomy
Figure 2: Flow chart indicating preferred surgical technique. Dotted lines are optional pathways. Laparoscopic procedures can convert to
open surgery. ∗Kimura = spleen-preserving distal pancreatectomy with preservation of the splenic vessels. #Warshaw = spleen-preserving
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Figure 3: Splenic blood supply. (a) Short gastric arteries; (b) left
gastroepiploic artery; (c) splenic artery.
cancer. The statement did mention that the evidence-base is
weak for these recommendations. See Figure 4 for a detailed
illustration of peripancreatic lymph node stations.
A laparoscopic approach to the RAMPS is considered a
technically difficult procedure, but it appears to be feasible
laparoscopically [41]. The current evidence on laparoscopic
RAMPS for pancreatic ductal adenocarcinoma is limited and,
therefore, until now it is uncertain whether the oncological
feasibility of laparoscopic and open approach is compa-
rable. A recent systematic review by Ricci et al. included
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Figure 4: Peripancreatic lymph node stations. According to the
International Study Group on Pancreatic Surgery guidelines during
distal pancreatectomy for cancer lymph nodes in stations 10, 11, and
18 have to be resected. Resection of lymph nodes in stations 8a and 9
is optional, but it is suggested to be included in the resection in case
of cancer located in the body of the pancreas [6].
for pancreatic cancer [42]. They found resection margins,
lymph node retrieval, and survival to be comparable for
both groups [42]. However, the available evidence is limited
and further research is needed. For safety duties, one of the
most recent series on this topic stated that patients suitable
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for a laparoscopic approach should meet the Yonsei criteria,
defined as tumors which are confined to the pancreas, located
1-2 cm from the celiac trunk, with an intact fascial layer
between the distal pancreas, the left adrenal gland, and the left
kidney [41]. A flow chart is shown in Figure 2, summarizing
which surgical procedure is preferred. The decision whether
a laparoscopic or open approach has to be chosen needs to
be made according to the surgeon’s preference and may be
based on several factors, such as the surgeon’s experience,
tumor size, involvement of other organs (adrenal, duodenum,
stomach, colon, or kidney), and tumor morphology (e.g.,
infiltrating growth or inflammation).
During laparoscopic resection for cancer it is probably
advisable to avoid more than 30-degree left tilt. More tilt may
worsen the access for lymphadenectomy around the hepatic
artery and celiac trunk. Placement of an additional trocar
at the right of the infraumbilical camera port, as shown in
Figure 1, will further facilitate this lymphadenectomy.
3.2. Postoperative Pancreatic Fistula. Although the mortality
associated with pancreatectomy has decreased, the morbidity
remains high, ranging from relatively low to very high
percentages [43, 44]. The most frequent complication after
distal pancreatectomy is a postoperative pancreatic fistula,
occurring in 4% to 69% of patients [45, 46]. POPFs are
associated with several further complications, such as intra-
abdominal abscesses, subsequent sepsis, wound infection,
delayed gastric emptying, ileus, and postpancreatectomy
hemorrhage.
The International Study Group on Pancreatic Fistula
(ISGPF) developed a consensus definition and grading scale
to aid in classifying POPFs [47]. The definition of a post-
operative POPF is drain output of any volume on or after
postoperative day 3 with an amylase greater than 3 times
the upper normal serum level. Many factors influence POPF,
including patient-related risk factors (age, sex, and bodymass
index), disease-related risk factors (pancreatic gland texture
and pancreatic duct size), procedure-related risk factors
(operative time, transection, technique, closure technique,
and intraoperative blood loss), and the surgeon’s experience
[48–50].
Unfortunately, we can conclude that a laparoscopic
approach to distal pancreatectomy failed in reducing the rate
of POPF [51, 52]. Nevertheless laparoscopy is associated with
better outcomes than open surgery, so new methods for the
prevention of POPF should be applicable during or after
laparoscopic surgery.
The ISGPF definition of POPF seems not to be ideal
for laparoscopy since the length of hospital stay is reduced
when compared to conventional surgery and therefore more
patients will go homewith a drain in situ [1, 15, 16]. According
to the ISGPF definition, patients are having grade B POPF,
rather than grade A, when they are discharged with a surgical
drain [47]. After laparoscopy, the decision to discharge a
patient is not driven by the presence of a surgical drain
and many patients will be able to go home on day 3 or 4
postoperatively. Due to the definition, this could potentially
somewhat increase the reported rate of grade B POPF.
Once the diagnosis of POPF is established, conservative
management leads to successful outcome in about 90% of
cases [53]. Depending on the patient’s clinical conditions,
sometimes interventional radiological assistance is required,
but reoperation is very rarely indicated [48, 54]. Several
resection methods and closure techniques of protecting the
pancreatic remnant have been developed especially in an
effort to reduce POPF after laparoscopic distal pancreatec-
tomy. These include transection and closure using a stapling
device, oversewing the staple line, pancreatic transection
using various energy devices, staple line reinforcement,
reinforcement of the pancreatic stump with a jejunal loop,
gastric anastomosis or falciform ligament patch, sealing
with fibrin sealant patches, pancreatic sphincterotomy, and
administration of somatostatin analogues.Most of these tech-
niques can be applied during laparoscopic surgery. Hereafter,
we summarize the evidence of the four most important
approaches to the prevention of POPF.
3.2.1. Preventing Fistula 1: Perioperative Endoscopic Interven-
tion. Perioperative endoscopic pancreatic sphincterectomy
has been proposed to prevent POPF, mainly after distal
pancreatectomy [55, 56].This technique is highly feasible and
is usually well tolerated by patients [57]. Recent randomized
controlled trials showed that prophylactic pancreatic stenting
does not reduce POPF after distal pancreatectomy [58]. In
fact, it increased bacterial seeding in the stent, leading to
formation of abscesses. The ongoing randomized controlled
trials in Sweden and the United States will hopefully be able
to show the true value of this technique [59, 60].
3.2.2. Preventing Fistula 2: Transection and Closure Tech-
niques. Several techniques for transecting the pancreas and
treating the pancreatic remnant after distal pancreatectomy
have been reported [61–68]. Until now, only Suzuki et al.
concluded from the first randomized controlled trial that
the use of ultrasonic dissectors significantly reduced the
incidence of POPF [69].
Hand-sewn closure and stapler closure represent themost
common techniques of pancreatic remnant management and
can both be performed during laparoscopic distal pancreatec-
tomy.The evidence showed that stapler closure is not superior
to hand-sewn closure [46, 70]. Recently, the DISPACT trial
showed that incidence of POPF after hand-sewn closure was
not reduced compared with stapler closure, as it was 28%
versus 32%, respectively (𝑃 = 0.56) [71].This outcome is quite
relevant, as stapler closure is the preferred technique during
laparoscopic distal pancreatectomy.The results obtainedwith
stapler closure might be improved by advances in stapling
devices. For instance dividing the pancreas using 2.5mm
vascular staple cartridges significantly decreased the rate of
clinically significant pancreatic fistula comparedwith 4.5mm
staple cartridges [72]. Furthermore, gradual closing of the
stapler over the course of about 2 to 3 minutes could reduce
POPF rates as reported by Asbun and Stauffer [73]. They
reported a cohort of laparoscopic distal pancreatectomies and
applied this stepwise stapler closing method, which resulted
in an acceptable grade B/C POPF rate of 6.6% [73].
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In recent years some evidence on the effect of reinforce-
ment of a stapled transection line on POPF appeared. In 2008,
an American research group published promising results, as
they found that staple line reinforcement after distal pancrea-
tectomy significantly reduced the POPF rate from 25% to 10%
(𝑃 < 0.02) [74]. A few years later, this was confirmed in a
randomized controlled trial from Hamilton et al. [75]. They
randomized 100 patients to either mesh (𝑛 = 54) or no mesh
(𝑛 = 46) reinforcement of the pancreatic transection line
and found ISGPF grade B/C POPF to be reduced significantly
from 20% to 1% in case of a mesh (𝑃 = 0.0007).
3.2.3. Preventing Fistula 3: Glue and Patches. During laparo-
scopic distal pancreatectomy some other techniques of POPF
prevention could be utilized, such as fibrin glue and sealant
patches [76–82]. However, the results of retrospective reviews
and trials are contrary and, therefore, the use of these tech-
niques is the subject of further research and discussion.There
have been reports using gastric and jejunal patches, covering
the pancreatic stump. Moriura et al. reported that pancreas
related complications decreased when using a seromuscular
patch [83]. However, these results were not confirmed in the
randomized controlled trial by Ola´h et al., in which grade
B/C POPFs after stapler transection and stapler transection
combinedwith a seromuscular patchwere found to be similar
[84]. Additionally, the application of a falciform ligament
patch and fibrin glue to standard stapled or sutured remnant
closure did not reduce the rate of POPF in patients undergo-
ing distal pancreatectomy [85]. In 2012, Montorsi et al. [82]
published the results of a randomized controlled trial on the
effect of an absorbable fibrin sealant patch on POPF after
distal pancreatectomy. In total, 275 patients were enrolled,
of which 145 were allocated to the absorbable fibrin sealant
patch group and 130 to the control group. This study showed
comparable POPF rates in both groups, both for total POPF
rates and grade B/C POPF rates [82]. To date, it is unclear
whether these kinds of interventionswill decrease POPF rates
significantly after laparoscopic distal pancreatectomy or not.
3.2.4. Preventing Fistula 4: Somatostatin Analogues. Somato-
statin is an inhibitor of endocrine and exocrine pancreatic
activity. The use of somatostatin analogues for preventing
POPF is controversial [86]. However, Gurusamy et al. con-
ducted a Cochrane analysis and showed reduction of compli-
cations and POPF rate using somatostatin analogues, without
decreasing clinical relevant POPF rates [87]. The efficacy
of prophylactic somatostatin analogues was reported to be
improved, by selective administration in the setting of high-
risk patients, including patients with a soft pancreatic gland,
a small pancreatic duct or patients in whom intraoperative
blood loss was excessive [88]. Since evidence on the benefit of
its use is still lacking, administration based on the surgeon’s
interpretation of the risk of POPF at the time of surgery is
required to establish clear guidelines [89]. Interestingly, the
newest results from a trial by Allen et al. [90] showed that
the use of pasireotide (a long half-life somatostatin analogue)
in the perioperative period significantly reduced risk of
clinically relevant POPF after distal pancreatectomy [90].
4. Conclusion
The laparoscopic approach to distal pancreatectomy is sug-
gested to be associated with improved time to recovery and
improved rates of spleen-preserving distal pancreatectomy,
but randomized studies are still lacking. Several randomized
controlled trials have reported effective techniques to prevent
postoperative pancreatic fistula (seromuscular jejunal patch,
mesh reinforcement, and pasireotide injection), but no strat-
egy has been confirmed in a second consecutive randomized
controlled trial. Further research on the prevention of POPF
is warranted.
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